CSGALNACT1 antisense RNA 1 (CSGALNACT1-AS1)

CSGALNACT1 antisense RNA 1 (CSGALNACT1-AS1) is a long non-coding RNA transcribed in the antisense orientation relative to the protein-coding CSGALNACT1 gene. Antisense lncRNAs have emerged as important regulatory molecules that can modulate gene expression at multiple levels, including chromatin remodeling, transcriptional interference, or RNA stability, often acting in a locus-specific manner[4]. However, as of current knowledge, CSGALNACT1-AS1 itself has not been characterized as a functional molecule in disease or physiology, and no direct evidence links it to specific drug mechanisms or therapeutic applications. This distinguishes it from more widely studied antisense lncRNAs, such as those regulating immune response or imprinting, where functional and therapeutic relevance have been established[4]. Therefore, CSGALNACT1-AS1 is best classified as a genomic regulatory element of emerging interest, with unknown clinical or biomarker utility. No evidence was found associating CSGALNACT1-AS1 with common druggable target classes (such as receptor, enzyme, or transporter), nor is it currently considered a direct therapeutic target. There is also no apparent error in the spelling or nature of the query; it is a valid lncRNA entity, albeit with limited published functional or clinical information. If precise functional or therapeutic roles are discovered in newer literature, these should be added as the field of lncRNA research advances.

Other names

CSGALNACT1-AS1

Not applicable; no drugs target this lncRNA as of current knowledge